The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Samama, M. M., Cohen, A. T., Darmon, J.-Y., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Nguyen, H., Olsson, C.-G., Turpie, A. G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411103 · Cited by 1,584
Fisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,464
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Heit, J. A., O'Fallon, W. M., Petterson, T. M., Lohse, C. M., Silverstein, M. D., Mohr, D. N., & Melton, L. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.11.1245 · Cited by 1,104
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Leizorovicz, A., Cohen, A. T., Turpie, A. G. G., Olsson, C.-G., Vaitkus, P. T., & Goldhaber, S. Z. (2004) · Circulation · doi:10.1161/01.cir.0000138928.83266.24 · Cited by 955
Rajkumar, S. V., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S., Katz, M., & Greipp, P. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70284-0 · Cited by 933
Self-citationFacon, T., Mary, J. Y., Hulin, C., Benboubker, L., Attal, M., Pegourie, B., Renaud, M., Harousseau, J. L., Guillerm, G., Chaleteix, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61537-2 · Cited by 869
Self-citationRajkumar, S. V., Blood, E., Vesole, D., Fonseca, R., & Greipp, P. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0221 · Cited by 865
Self-citationCohen, A. T., Davidson, B. L., Gallus, A. S., Lassen, M. R., Prins, M. H., Tomkowski, W., Turpie, A. G. G., Egberts, J. F. M., & Lensing, A. W. A. (2006) · BMJ · doi:10.1136/bmj.38733.466748.7c · Cited by 857
Palumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 809
Self-citationRichardson, P. G., Schlossman, R. L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., LeBlanc, R., Catley, L. P., Doss, D., Kelly, K., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0996 · Cited by 804
Self-citationBern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 788
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma
Barlogie, B., Tricot, G., Anaissie, E., Shaughnessy, J., Rasmussen, E., van Rhee, F., Fassas, A., Zangari, M., Hollmig, K., Pineda-Roman, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053583 · Cited by 739
Self-citationSamama, M.-M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3415 · Cited by 695
Baglin, T., Luddington, R., Brown, K., & Baglin, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14111-6 · Cited by 694
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
Rajkumar, S. V., Hayman, S. R., Lacy, M. Q., Dispenzieri, A., Geyer, S. M., Kabat, B., Zeldenrust, S. R., Kumar, S., Greipp, P. R., Fonseca, R., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2817 · Cited by 648
Self-citationEyer, M. M., Amama, M. I. S., Lexander, A., Ohen, T. H. C., Ean, J., Armon, V. D., Esjardins, L. O. D., Ldor, A. M. E., Anbon, C. H. J., Eizorovicz, A. L. L., et al. (1999) · Cited by 623
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Verso, M., & Agnelli, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.008 · Cited by 605
Zhou, H., Romano, P., & White, R. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-03-0152 · Cited by 598
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.445 · Cited by 594
NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS
LAGERSTEDT, C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90459-3 · Cited by 569
Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma
Weber, D., Rankin, K., Gavino, M., Delasalle, K., & Alexanian, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.139 · Cited by 566
Self-citationDentali, F., Douketis, J. D., Gianni, M., Lim, W., & Crowther, M. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-4-200702200-00007 · Cited by 544
Barlogie, B., Desikan, R., Eddlemon, P., Spencer, T., Zeldis, J., Munshi, N., Badros, A., Zangari, M., Anaissie, E., Epstein, J., et al. (2001) · Blood · doi:10.1182/blood.v98.2.492 · Cited by 541
Self-citationCancer and venous thromboembolism
Prandoni, P., Falanga, A., & Piccioli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70207-2 · Cited by 540
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Fisher, B., Dignam, J., Emir, B., Bryant, J., DeCillis, A., Wolmark, N., Wickerham, D. L., Dimitrov, N. V., Abramson, N., Atkins, J. N., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.22.1673 · Cited by 521
Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
Rajkumar, S. V., Hayman, S., Gertz, M. A., Dispenzieri, A., Lacy, M. Q., Greipp, P. R., Geyer, S., Iturria, N., Fonseca, R., Lust, J. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.116 · Cited by 512
Self-citationLevine, M., Hirsh, J., Arnold, A., Gent, M., Levine, M., Arnold, A., Bramwell, V., Pritchard, K. I., Stewart, D., Warr, D., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 510
Zangari, M., Anaissie, E., Barlogie, B., Badros, A., Desikan, R., Gopal, A. V., Morris, C., Toor, A., Siegel, E., Fink, L., et al. (2001) · Blood · doi:10.1182/blood.v98.5.1614 · Cited by 491
Self-citationAntithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2004) · Chest · doi:10.1378/chest.126.3_suppl.483s · Cited by 466
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
Wan, J., Nguyen, N., & Sallah, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613051 · Cited by 411
Taube, J., Halsall, D., & Baglin, T. (2000) · Blood · doi:10.1182/blood.v96.5.1816 · Cited by 392
Laporte-Simitsidis, S., Tardy, B., Cucherat, M., Buchmüller, A., Juillard-Delsart, D., Decousus, H., & Mismetti, P. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613749 · Cited by 373
The Prophylactic Portacaval Shunt
(1972) · The Lancet · doi:10.1016/s0140-6736(72)91163-4 · Cited by 373
Monreal, M., Alastrue, A., Rull, M., Mira, X., Muxart, J., Rosell, R., & Abad, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650254 · Cited by 370
Palumbo, A., Falco, P., Corradini, P., Falcone, A., Di Raimondo, F., Giuliani, N., Crippa, C., Ciccone, G., Omedè, P., Ambrosini, M. T., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3463 · Cited by 319
Self-citationPositron Emission Tomography As an Imaging Biomarker
Weber, W. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6068 · Cited by 312
The relationship between inflammation and venous thrombosis: A systematic review of clinical studies
Fox, E. A., & Kahn, S. R. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-04-0266 · Cited by 275
Zangari, M., Siegel, E., Barlogie, B., Anaissie, E., Saghafifar, F., Fassas, A., Morris, C., Fink, L., & Tricot, G. (2002) · Blood · doi:10.1182/blood-2002-01-0335 · Cited by 262
Self-citationAssessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
Alikhan, R., Arcelus, J. I., Bergmann, J.-F., Haas, S., Merli, G. J., Spyropoulos, A. C., Tapson, V. F., Turpie, A. G. G., & Cohen, A. T. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-06-0385 · Cited by 249
Alikhan, R., Cohen, A. T., Combe, S., Samama, M. M., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Olsson, C.-G., & Turpie, A. G. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200306000-00004 · Cited by 244
Lenalidomide and Venous Thrombosis in Multiple Myeloma
(2006) · New England Journal of Medicine · doi:10.1056/nejmc053530 · Cited by 232
Deep Venous Thrombosis and Thalidomide Therapy for Multiple Myeloma
Osman, K., Comenzo, R., & Rajkumar, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442516 · Cited by 228
Self-citationBaz, R., Li, L., Kottke-Marchant, K., Srkalovic, G., McGowan, B., Yiannaki, E., Karam, M. A., Faiman, B., Jawde, R. A., Andresen, S., et al. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.12.1568 · Cited by 228
Self-citationThalidomide as initial therapy for early-stage myeloma
Rajkumar, S. V., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Geyer, S. M., Iturria, N., Kumar, S., Lust, J. A., Kyle, R. A., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402866 · Cited by 225
Self-citationZangari, M., Barlogie, B., Anaissie, E., Saghafifar, F., Eddlemon, P., Jacobson, J., Lee, C., Thertulien, R., Talamo, G., Thomas, T., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05078.x · Cited by 220
Self-citationProphylaxis for Thromboembolism in Hospitalized Medical Patients
Francis, C. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp067264 · Cited by 195
The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications
Bauer, K. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-5-200109040-00013 · Cited by 193
Cavo, M., Zamagni, E., Tosi, P., Cellini, C., Cangini, D., Tacchetti, P., Testoni, N., Tonelli, M., Vivo, A. D., Palareti, G., et al. (2004) · PubMed · Cited by 191
Self-citationThalidomide and dexamethasone for resistant multiple myeloma
Anagnostopoulos, A., Weber, D., Rankin, K., Delasalle, K., & Alexanian, R. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04345.x · Cited by 177
Self-citationLee, C.-K., Barlogie, B., Munshi, N., Zangari, M., Fassas, A., Jacobson, J., van Rhee, F., Cottler-Fox, M., Muwalla, F., & Tricot, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.055 · Cited by 175
Self-citationSrkalovic, G., Cameron, M. G., Rybicki, L., Deitcher, S. R., Kattke‐Marchant, K., & Hussein, M. A. (2004) · Cancer · doi:10.1002/cncr.20405 · Cited by 172
Self-citationGarcía-Sanz, R., González-Porras, J. R., Hernández, J. M., Polo-Zarzuela, M., Sureda, A., Barrenetxea, C., Palomera, L., López, R., Grande-García, C., Alegre, A., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403322 · Cited by 159
Self-citationDimopoulos, M. A., Hamilos, G., Zomas, A., Gika, D., Efstathiou, E., Grigoraki, V., Poziopoulos, C., Xilouri, I., Zorzou, M. P., Anagnostopoulos, N. I., et al. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200326 · Cited by 150
Self-citationBaz, R., Walker, E., Karam, M. A., Choueiri, T. K., Jawde, R. M. A., Bruening, K., Reed, J., Faiman, B. M., Ellis, Y., Brand, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl313 · Cited by 147
Self-citationZonder, J. A., Barlogie, B., Durie, B. G. M., McCoy, J., Crowley, J. J., & Hussein, M. A. (2006) · Blood · doi:10.1182/blood-2006-01-0154 · Cited by 146
Self-citationRajkumar, S. V., Jacobus, S. J., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S. D., & Greipp, P. T. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.lba8025 · Cited by 145
Self-citationEfficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma
Palumbo, A., Bertola, A., Falco, P., Rosato, R., Cavallo, F., Giaccone, L., Bringhen, S., Musto, P., Pregno, P., Caravita, T., et al. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200403 · Cited by 140
Self-citationKropff, M. H., Lang, N., Bisping, G., Dominé, N., Innig, G., Hentrich, M., Mitterer, M., Südhoff, T., Fenk, R. R., Straka, C., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04473.x · Cited by 140
The relative role of PLCβ and PI3Kγ in platelet activation
Lian, L., Wang, Y., Draznin, J., Eslin, D. E., BENNETT, J. S., Poncz, M., Wu, D., & Abrams, C. S. (2005) · Blood · doi:10.1182/blood-2004-05-2005 · Cited by 134
Thrombotic Complications of Central Venous Catheters in Cancer Patients
Bona, R. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994916 · Cited by 129
Zervas, K., Dimopoulos, M. A., Hatzicharissi, E., Anagnostopoulos, Α., Papaioannou, M., Mitsouli, C., Panagiotidis, P., Korantzis, J., Tzilianos, M., & Maniatis, A. G. (2003) · Annals of Oncology · doi:10.1093/annonc/mdh026 · Cited by 126
Self-citationDimopoulos, M. A., Spencer, A. G., Attal, M., Prince, M., Harousseau, J., Dmoszyńska, A., Yu, Z., Olesnyckyj, M., Zeldis, J. B., & Knight, R. (2005) · Blood · doi:10.1182/blood.v106.11.6.6 · Cited by 113
Self-citationThalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival
Zangari, M., Barlogie, B., Thertulien, R., Jacobson, J. L., Eddleman, P., Fink, L. M., Fassas, A., van Rhee, F., Talamo, G., Lee, C.-K., et al. (2003) · Clinical Lymphoma · doi:10.3816/clm.2003.n.011 · Cited by 112
Self-citationDose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.
Neben, K., Moehler, T. M., Benner, A., Kraemer, A., Egerer, G., Ho, A. D., & Goldschmidt, H. (2002) · PubMed · Cited by 105
Offidani, M. (2006) · Blood · doi:10.1182/blood-2006-03-013086 · Cited by 103
Morgan, G. J., Schey, S., Wu, P., Srikanth, M., Phekoo, K. J., Jenner, M. W., & Davies, F. E. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06538.x · Cited by 101
Self-citationProthrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma
Auwerda, J. J. A., Sonneveld, P., de Maat, M. P. M., & Leebeek, F. W. G. (2007) · Haematologica · doi:10.3324/haematol.10454 · Cited by 96
Self-citationSallah, S., Husain, A., Wan, J. Y., Vos, P. W., & Nguyen, N. P. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh385 · Cited by 85
Weber, D. M., Chen, C., Niesvizky, R., Wang, M., Belch, A. R., Stadtmauer, E. A., Yu, Z., Olesnyckyj, M., Zeldis, J. B., & Knight, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.7521 · Cited by 73
Self-citationSchey, S., Cavenagh, J. D., Johnson, R. J., Child, J. A., Oakervee, H. E., & Jones, R. W. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00027-4 · Cited by 66
Wu, P., Davies, F. E., Horton, C., Jenner, M. W., Krishnan, B., Alvares, C. L., Saso, R. M., Mccormack, R., Dines, S., Treleaven, J. G., et al. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600821955 · Cited by 49
Self-citationSchütt, P., Ebeling, P. R., Buttkereit, U., Brandhorst, D., Opalka, B., Hoiczyk, M., Flaßhove, M., Hense, J., Bojko, P., Metz, K. A., et al. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00349.x · Cited by 49
The HOX-MEIS connection in AML
Lawrence, H. J., & Largman, C. (2005) · Blood · doi:10.1182/blood-2005-04-1582 · Cited by 47
Dimopoulos, M. A., Anagnostopoulos, A., Terpos, E., Repoussis, P., Zomas, A., Katodritou, E., Kyrtsonis, M. C., Delibasi, S., Vassou, A., Pouli, A. G., et al. (2006) · PubMed · Cited by 46
Self-citationThrombotic Complications of Myeloma Therapy
Zonder, J. A. (2006) · Hematology · doi:10.1182/asheducation-2006.1.348 · Cited by 41
Self-citationThalidomide–dexamethasone as primary therapy for advanced multiple myeloma
Wang, M. L., Weber, D. M., Delasalle, K. B., & Alexanian, R. (2005) · American Journal of Hematology · doi:10.1002/ajh.20382 · Cited by 39
Self-citationRichardson, P. G. G., Schlossman, R. L., Munshi, N. C., Avigan, D., Jagannath, S., Alsina, M., Doss, D. S., McKenney, M., Hande, K., Farrell, M., et al. (2005) · Blood · doi:10.1182/blood.v106.11.365.365 · Cited by 35
Self-citationThalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma
Offidani, M., Corvatta, L., Marconi, M., Olivieri, A., Catarini, M., Mele, A., Brunori, M., Candela, M., Malerba, L., Capelli, D., et al. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200401 · Cited by 32
Imaging diagnosis of acute pulmonary embolism
Bozlar, U., Gaughen, J. R., Nambiar, A., & Hagspiel, K. D. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.3.519 · Cited by 12
Research works printed but not linked: 12
- Ageno W, Squizzato A, Garcia D, Imberti D . Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 2006; 32: 651–658. · doi:10.1055/s-2006-951293
- Bick RL . Cancer-associated thrombosis. N Engl J Med 2003; 349: 109–111. · doi:10.1056/nejmp030086
- Zangari M, Saghafifar F, Mehta P, Barlogie B, Fink L, Tricot G . The blood coagulation mechanism in multiple myeloma. Semin Thromb Hemost 2003; 29: 275–282. · doi:10.1055/s-2003-40965
- Sidra G, Williams CD, Russell NH, Zaman S, Myers B, Byrne JL . Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma. Haematologica 2006; 91: 862–863.
- Suvannasankha A, Fausel C, Juliar BE, Yiannoutsos CT, Fisher WB, Ansari RH et al. Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: a Hoosier Oncology Group Trial, HEM01-21. Oncologist 2007; 12: 99–106. · DOI
- Galli M, Elice F, Crippa C, Comotti B, Rodeghiero F, Barbui T . Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma. Haematologica 2004; 89: 1141–1142.
- Haas SK . Venous thromboembolic risk and its prevention in hospitalized medical patients. Semin Thromb Hemost 2002; 28: 577–584. · doi:10.1055/s-2002-36702
- Minnema MC, Breitkreutz I, Auwerda JJ, van der Holt B, Cremer FW, van Marion AM et al. Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy. Leukemia 2004; 18: 2044–2046. · doi:10.1038/sj.leu.2403533
- Zangari M, Barlogie B, Lee CK, Tricot AE, Fassas A, Anaissie E et al. Protective effect of VELCADE® on thalidomide-associated deep vein thrombosis (DVT). Blood 2004; 104: 13a (abstract [4914]). · doi:10.1182/blood.v104.11.13.13
- Cestac P, Bagheri H, Lapeyre-Mestre M, Sie P, Fouladi A, Maupas E et al. Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients. Drug Saf 2003; 26: 197–207. · doi:10.2165/00002018-200326030-00005
- Nagge J, Crowther M, Hirsh J . Is impaired renal function a contraindication to the use of low-molecular-weight heparin? Arch Intern Med 2002; 162: 2605–2609. · doi:10.1001/archinte.162.22.2605
- Moser KM, Fedullo PF, LittleJohn JK, Crawford R . Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223–225. · doi:10.1001/jama.1994.03510270069042
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Palumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Self-citationLyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Self-citation
Metadata
- Authors
- Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., Attal, M., Belch, A., Knop, S., Joshua, D., Sezer, O., Ludwig, H., Vesole, D., Bladé, J., Kyle, R., Westin, J., Weber, D., Bringhen, S., Niesvizky, R., Waage, A., von Lilienfeld-Toal, M., Lonial, S., Morgan, G. J., Orlowski, R. Z., Shimizu, K., Anderson, K. C., Boccadoro, M., Durie, B. G., Sonneveld, P., Hussein, M. A., & on behalf of the International Myeloma Working Group
- Venue
- Leukemia
- Published
- 2007-12-20
- Volume
- 22
- Issue
- 2
- Pages
- 414-423
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2097331346
- Cited by
- 840
- References
- 93
- FWCI
- 34.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.